Atazanavir D18
| Product Name | Atazanavir D18 |
|---|---|
| Alternate Names | Atazanavir Stable Isotopes, Stable Isotopes of Atazanavir |
| CAT No. | CS-T-48392 |
| CAS No. | 1092540-52-7 |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Atazanavir |
| Therapeutic | Antiretroviral / Anti-HIV |
| Smileys | O[C@H]([C@@H](NC([C@H](C(C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])NC(OC)=O)=O)CC1=CC=CC=C1)CN(NC([C@H](C(C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])NC(OC)=O)=O)CC2=CC=C(C3=CC=CC=N3)C=C2 |
| Canonical Smiles | CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC |
| InchIKey | AXRYRYVKAWYZBR-AAPVVJSESA-N |
| Inchl | InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1/i1D3,2D3,3D3,4D3,5D3,6D3 |
| IUPAC | methyl N-[(2S)-4,4,4-trideuterio-1-[[(2S,3S)-3-hydroxy-1-phenyl-4-[(4-pyridin-2-ylphenyl)methyl-[[(2S)-4,4,4-trideuterio-2-(methoxycarbonylamino)-3,3-bis(trideuteriomethyl)butanoyl]amino]amino]butan-2-yl]amino]-1-oxo-3,3-bis(trideuteriomethyl)butan-2-yl]carbamate |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Atazanavir D18 is a medication that falls under the category of antiretroviral drugs. It is primarily used in the treatment of HIV (Human Immunodeficiency Virus) infections and AIDS (Acquired Immunodeficiency Syndrome). The drug works by inhibiting the activity of HIV protease, an enzyme that is required for the virus to replicate and produce new infectious particles. This effectively reduces the viral load in the patient's bloodstream and helps to slow down the progression of the disease.
Atazanavir D18 is typically taken orally in the form of a capsule or tablet. The recommended dosage varies depending on the patient's age, weight, and overall health status. It is important to follow the prescribed regimen strictly to ensure the medication's effectiveness and minimize the risk of adverse side effects.
Regarding its chemical composition, Atazanavir D18 belongs to a class of compounds called azapeptides. Its molecular formula is C38H52N6O7S2, and it has a molecular weight of 758.98 g/mol. The drug is primarily metabolized in the liver and excreted through the kidneys.
As with any medication, Atazanavir D18 has some potential side effects, including nausea, diarrhea, abdominal pain, headache, and skin rashes. In rare cases, it may cause more serious adverse reactions such as liver damage or pancreatitis. Patients should consult their healthcare provider if they experience any unusual symptoms while taking the medication.
Get an Instant Quote
Related Compounds
Atazanavir D9 | Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir-d5 | Atazanavir D6 | Atazanavir D4 | Atazanavir D24 | Des-N-(methoxycarbonyl)-L-tert-leucine Atazanavir-d5 Trihydrochloride |